HTG Molecular Diagnostics, Inc. Net Income (Loss) Available to Common Stockholders, Basic
HTG Molecular Diagnostics, Inc. reported Net Income (Loss) Available to Common Stockholders, Basic of -$26.04 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-23.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2017-03-23
- HTG Molecular Diagnostics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-12-31 was -$5.67M.
- HTG Molecular Diagnostics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-09-30 was -$6.49M.
- HTG Molecular Diagnostics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-06-30 was -$6.85M.
- HTG Molecular Diagnostics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-03-31 was -$7.03M.
- HTG Molecular Diagnostics, Inc. net income (loss) available to common stockholders, basic for fiscal 2016 was -$26.04M.
- HTG Molecular Diagnostics, Inc. net income (loss) available to common stockholders, basic for fiscal 2015 was -$22.73M.
- HTG Molecular Diagnostics, Inc. net income (loss) available to common stockholders, basic for fiscal 2014 was -$17.62M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$5.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | -$12.16M derived: sum of 2 quarters · filed 2017-03-23 | -$19.01M derived: sum of 3 quarters · filed 2017-03-23 | -$26.04M 10-K · filed 2017-03-23 |
| 2016-09-30 | -$6.49M 10-Q · filed 2016-11-14 | -$13.34M derived: sum of 2 quarters · filed 2016-11-14 | -$20.37M 10-Q · filed 2016-11-14 | -$26.07M derived: sum of 4 quarters · filed 2017-03-23 |
| 2016-06-30 | -$6.85M 10-Q · filed 2016-08-09 | -$13.88M 10-Q · filed 2016-08-09 | -$19.58M derived: sum of 3 quarters · filed 2017-03-23 | -$24.74M derived: sum of 4 quarters · filed 2017-03-23 |
| 2016-03-31 | -$7.03M 10-Q · filed 2016-05-12 | -$12.73M derived: sum of 2 quarters · filed 2017-03-23 | -$17.88M derived: sum of 3 quarters · filed 2017-03-23 | -$24.75M derived: sum of 4 quarters · filed 2017-03-23 |
| 2015-12-31 | -$5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | -$10.86M derived: sum of 2 quarters · filed 2017-03-23 | -$17.73M derived: sum of 3 quarters · filed 2017-03-23 | -$22.73M 10-K · filed 2017-03-23 |
| 2015-09-30 | -$5.16M 10-Q · filed 2016-11-14 | -$12.03M derived: sum of 2 quarters · filed 2016-11-14 | -$17.03M 10-Q · filed 2016-11-14 | -$22.10M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$6.87M 10-Q · filed 2016-08-09 | -$11.87M 10-Q · filed 2016-08-09 | -$16.94M derived: sum of 3 quarters · filed 2016-08-09 | -$21.20M derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | -$5.00M 10-Q · filed 2016-05-12 | -$10.07M derived: sum of 2 quarters · filed 2016-05-12 | -$14.33M derived: sum of 3 quarters · filed 2016-05-12 | -$19.11M derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | -$5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$9.33M derived: sum of 2 quarters · filed 2016-03-25 | -$14.11M derived: sum of 3 quarters · filed 2016-03-25 | -$17.62M 10-K · filed 2016-03-25 |
| 2014-09-30 | -$4.26M 10-Q · filed 2015-11-12 | -$9.04M derived: sum of 2 quarters · filed 2015-11-12 | -$12.55M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | -$4.78M 10-Q · filed 2015-08-07 | -$8.43M 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | -$3.64M 10-Q · filed 2015-06-08 |